These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35449431)

  • 1. Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain.
    Rubio de Santos M; Artime E; Duque N; Díaz-Cerezo S; Spaepen E; Carreño Á; Fernández A
    Diabetes Ther; 2022 Jun; 13(6):1147-1160. PubMed ID: 35449431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain.
    Ampudia-Blasco FJ; Duque N; Artime E; Caveda E; Spaepen E; Díaz-Cerezo S; de Santos MR; Velasco DC; Bahíllo-Curieses MP
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e451. PubMed ID: 37715339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics of insulin lispro 200 units/mL users in real world setting in Germany.
    Schloot NC; Perez-Nieves M; Sapin H; Kruppert S; Otto T; Corrigan SM; Piras de Oliveira C
    Curr Med Res Opin; 2020 Oct; 36(10):1611-1617. PubMed ID: 32845743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
    Chen J; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot N; Lara N; Garcia Alvarez L; Roset M
    Postgrad Med; 2020 Nov; 132(8):727-736. PubMed ID: 33108957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany.
    Chen J; Williams P; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot NC; Thun B; Blüher M
    Diabetes Ther; 2021 Nov; 12(11):2939-2953. PubMed ID: 34542865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.
    de la Peña A; Seger M; Soon D; Scott AJ; Reddy SR; Dobbins MA; Brown-Augsburger P; Linnebjerg H
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):69-75. PubMed ID: 27119580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes.
    Aronson R; Mahoney E; Saliu D; Sze D; Morel D; Bergquist L; Hirsch L
    Diabetes Technol Ther; 2020 May; 22(5):352-359. PubMed ID: 31692373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conversion of fast insulin intensive therapy to lispro insulin in type I diabetes. Pharmacoeconomic analysis of cost-effectiveness].
    Costa Pinel B; Belmonte Serrano M; Páez Vives F; Sabaté Obiol A; Estopá Sánchez A; Borrás Borrás J
    Rev Clin Esp; 2001 Aug; 201(8):448-54. PubMed ID: 11599156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Insulin Lispro Protamine Suspension in Pregnancy.
    Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
    Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study.
    Lane W; Faurby M; Husemoen LLN; Markovich DL; Rathor N; De Block C
    Diabetes Ther; 2021 Dec; 12(12):3067-3077. PubMed ID: 34637112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain.
    Norrbacka K; Sicras-Mainar A; Lebrec J; Artime E; Díaz S; Tofé-Povedano S; Hernández I; Romera I
    Diabetes Ther; 2021 May; 12(5):1535-1551. PubMed ID: 33860927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).
    Polonsky WH; Arora R; Faurby M; Fernandes J; Liebl A
    Diabetes Ther; 2022 Jan; 13(1):175-187. PubMed ID: 34918213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.